Indoco Remedies Limited (NSE:INDOCO)

Indoco Remedies Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-951.5	-737.37	984.6	1,423	1,548
Depreciation & Amortization	1,265	1,037	626.83	569.35	508.58
Other Amortization	-	101.06	291.82	136.72	263.51
Loss (Gain) From Sale of Assets	6	5.02	3.78	12.62	5.11
Asset Writedown & Restructuring Costs	-	-	-	-	17.47
Loss (Gain) From Sale of Investments	-	-6.59	-	-	-
Stock-Based Compensation	6.8	22.01	28.8	6.58	-
Provision & Write-off of Bad Debts	92.5	15.9	82.56	155.97	151.36
Other Operating Activities	947.6	484.09	420.22	216.44	332.11
Change in Accounts Receivable	-1,374	506.5	-637.83	-787.85	-587.77
Change in Inventory	141.4	-662.91	-270.78	-154.7	-726.65
Change in Accounts Payable	1,050	545.73	301.14	-86.55	214.29
Change in Other Net Operating Assets	739.1	-361.51	-277.27	297.2	12.27
Operating Cash Flow	1,922	949.27	1,554	1,788	1,738
Operating Cash Flow Growth	102.50%	-38.91%	-13.11%	2.88%	111.41%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-1,475	-3,562	-4,260	-2,073	-1,253
Sale of Property, Plant & Equipment	466.4	37.96	16.85	11.59	9.37
Investment in Securities	-	79.03	-62.44	-24.4	-0.02
Other Investing Activities	-7.2	53.45	-19.64	3.59	29.8
Investing Cash Flow	-1,016	-3,391	-4,325	-2,082	-1,214

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	1,003	1,382	181.18	-
Long-Term Debt Issued	1,465	2,643	2,511	950	975
Total Debt Issued	1,465	3,646	3,894	1,131	975
Short-Term Debt Repaid	-121.5	-	-	-	-139.04
Long-Term Debt Repaid	-874.9	-469.66	-528.66	-423.94	-991.83
Total Debt Repaid	-996.4	-469.66	-528.66	-423.94	-1,131
Net Debt Issued (Repaid)	468.6	3,176	3,365	707.24	-155.86
Issuance of Common Stock	13	15.9	7.73	-	-
Common Dividends Paid	-19.1	-139.02	-207.06	-207.21	-137.93
Other Financing Activities	-1,231	-639.11	-361.38	-271.99	-149.93
Financing Cash Flow	-768	2,414	2,804	228.04	-443.72

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	-	6.25	-	-
Net Cash Flow	138.2	-27.59	39.31	-65.41	80.48

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	447	-2,612	-2,706	-284.23	485.04
Free Cash Flow Growth	-	-	-	-	802.73%
Free Cash Flow Margin	2.42%	-15.69%	-14.89%	-1.70%	3.15%
Free Cash Flow Per Share	5.03	-28.33	-29.33	-3.08	5.26
Levered Free Cash Flow	-941.67	-2,917	-3,338	-855.72	-138.73
Unlevered Free Cash Flow	-177.61	-2,530	-3,120	-707.28	-35.87

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	1,227	639.11	361.38	271.99	149.93
Cash Income Tax Paid	61.7	171.22	294.86	616.54	410.81
Change in Working Capital	556.4	27.82	-884.74	-731.89	-1,088

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error